{"ticker": "ATRN", "overview": {"cik": "1022899", "ticker": "PTIX", "name": "Protagenic Therapeutics, Inc.\\new", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "4", "date": "2026-08-24", "title": "Insider transaction", "accession": "0001493152-26-039816", "price_sensitive": false}, {"form": "4", "date": "2026-08-20", "title": "Insider transaction", "accession": "0001493152-26-039537", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-20", "title": "Material event", "accession": "0001493152-26-039410", "price_sensitive": true}, {"form": "4", "date": "2026-08-20", "title": "Insider transaction", "accession": "0001493152-26-039399", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-19", "title": "Quarterly report", "accession": "0001493152-26-039221", "price_sensitive": true}, {"form": "NT 10-Q", "date": "2026-08-14", "title": "Form NT 10-Q", "accession": "0001493152-26-038256", "price_sensitive": false}, {"form": "10-K", "date": "2026-08-14", "title": "Annual report", "accession": "0001493152-26-038255", "price_sensitive": true}, {"form": "4", "date": "2026-08-12", "title": "Insider transaction", "accession": "0001493152-26-037468", "price_sensitive": false}, {"form": "4", "date": "2026-08-10", "title": "Insider transaction", "accession": "0001493152-26-036782", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001493152-26-036442", "price_sensitive": false}, {"form": "4", "date": "2026-08-03", "title": "Insider transaction", "accession": "0001493152-26-035868", "price_sensitive": false}, {"form": "NT 10-K", "date": "2026-06-30", "title": "Form NT 10-K", "accession": "0001493152-26-031235", "price_sensitive": false}, {"form": "8-K", "date": "2026-04-07", "title": "Material event", "accession": "0001493152-26-015365", "price_sensitive": true}, {"form": "10-Q", "date": "2026-03-09", "title": "Quarterly report", "accession": "0001493152-26-009301", "price_sensitive": true}, {"form": "8-K", "date": "2026-03-03", "title": "Material event", "accession": "0001493152-26-008605", "price_sensitive": true}, {"form": "8-K", "date": "2026-02-24", "title": "Material event", "accession": "0001493152-26-007800", "price_sensitive": true}, {"form": "NT 10-Q", "date": "2026-02-18", "title": "Form NT 10-Q", "accession": "0001493152-26-007254", "price_sensitive": false}, {"form": "25-NSE", "date": "2026-01-23", "title": "Form 25-NSE", "accession": "0001354457-26-000085", "price_sensitive": false}, {"form": "8-K", "date": "2026-01-05", "title": "Material event", "accession": "0001493152-26-000263", "price_sensitive": true}, {"form": "DEF 14A", "date": "2025-12-05", "title": "Proxy statement", "accession": "0001493152-25-026414", "price_sensitive": false}, {"form": "10-Q", "date": "2025-11-26", "title": "Quarterly report", "accession": "0001493152-25-025201", "price_sensitive": true}, {"form": "8-K", "date": "2025-11-26", "title": "Material event", "accession": "0001493152-25-025159", "price_sensitive": true}, {"form": "NT 10-Q", "date": "2025-11-14", "title": "Form NT 10-Q", "accession": "0001493152-25-023624", "price_sensitive": false}, {"form": "8-K", "date": "2025-11-05", "title": "Material event", "accession": "0001493152-25-020881", "price_sensitive": true}, {"form": "8-K", "date": "2025-10-31", "title": "Material event", "accession": "0001493152-25-020444", "price_sensitive": true}]}, "description": "", "exchange": null, "stats": {"buy_n": 3, "buy_sum": 591253.2276, "sell_n": 0, "sell_sum": 0, "net": 591253.2276, "insiders": 2, "first_date": "2009-12-21", "last_date": "2010-12-13"}, "metrics": {"ticker": "ATRN", "has_prices": false}, "trades": [{"id": "0001437749-16-034198", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Protagenic Therapeutics, Inc.\\new", "company_raw": "Protagenic Therapeutics, Inc.\\new", "who": "Robert Benjamin Stein", "who_key": "Stein Robert Benjamin", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 50000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000143774916034198/0001437749-16-034198-index.htm", "trade_date": "2016-06-17", "timestamp": "2016-06-17", "mins": 5458484}, {"id": "0001437749-16-034199", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Protagenic Therapeutics, Inc.\\new", "company_raw": "Protagenic Therapeutics, Inc.\\new", "who": "Khalil Barrage", "who_key": "Barrage Khalil", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 56250.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000143774916034199/0001437749-16-034199-index.htm", "trade_date": "2016-06-17", "timestamp": "2016-06-17", "mins": 5458484}, {"id": "0001437749-16-034201", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Protagenic Therapeutics, Inc.\\new", "company_raw": "Protagenic Therapeutics, Inc.\\new", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 56250.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000143774916034201/0001437749-16-034201-index.htm", "trade_date": "2016-06-17", "timestamp": "2016-06-17", "mins": 5458484}, {"id": "0001437749-16-034202", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Protagenic Therapeutics, Inc.\\new", "company_raw": "Protagenic Therapeutics, Inc.\\new", "who": "Garo H. Armen", "who_key": "ARMEN GARO H", "role": "See Remarks, Director, 10% Owner", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 625000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000143774916034202/0001437749-16-034202-index.htm", "trade_date": "2016-06-17", "timestamp": "2016-06-17", "mins": 5458484}, {"id": "0001437749-16-034203", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Protagenic Therapeutics, Inc.\\new", "company_raw": "Protagenic Therapeutics, Inc.\\new", "who": "Alexander K. Arrow", "who_key": "Arrow Alexander K.", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 175000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000143774916034203/0001437749-16-034203-index.htm", "trade_date": "2016-06-17", "timestamp": "2016-06-17", "mins": 5458484}, {"id": "0001437749-16-034209", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Protagenic Therapeutics, Inc.\\new", "company_raw": "Protagenic Therapeutics, Inc.\\new", "who": "Gregory Ekizian", "who_key": "Ekizian Gregory", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 56250.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000143774916034209/0001437749-16-034209-index.htm", "trade_date": "2016-06-17", "timestamp": "2016-06-17", "mins": 5458484}, {"id": "0001437749-16-031405", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Alexander K. Arrow", "who_key": "Arrow Alexander K.", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000143774916031405/0001437749-16-031405-index.htm", "trade_date": "2016-04-15", "timestamp": "2016-04-15", "mins": 5549204}, {"id": "0001144204-11-033761", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Brilliant Digital Entertainment Inc", "who_key": "BRILLIANT DIGITAL ENTERTAINMENT INC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "10% owner files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420411033761/0001144204-11-033761-index.htm", "trade_date": "2011-05-31", "timestamp": "2011-05-31", "mins": 8113844}, {"id": "0001144204-10-066734", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Raymond Musci", "who_key": "MUSCI RAYMOND", "role": "Exec VP, Corporate Development, Director", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 28457.94, "score": 32.8, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "A director backs ATRN with $28K", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410066734/0001144204-10-066734-index.htm", "trade_date": "2010-12-13", "timestamp": "2010-12-13", "mins": 8357204}, {"id": "0001144204-10-067071", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Raymond Musci", "who_key": "MUSCI RAYMOND", "role": "Exec VP, Corporate Development, Director", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 28457.94, "score": 33.3, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "A director backs ATRN with $28K", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410067071/0001144204-10-067071-index.htm", "trade_date": "2010-12-13", "timestamp": "2010-12-13", "mins": 8357204}, {"id": "0001144204-10-051795", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Lawrence Burstein", "who_key": "BURSTEIN LAWRENCE", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410051795/0001144204-10-051795-index.htm", "trade_date": "2010-09-28", "timestamp": "2010-09-28", "mins": 8466644}, {"id": "0001144204-10-051797", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Jerome A. Chazen", "who_key": "CHAZEN JEROME A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410051797/0001144204-10-051797-index.htm", "trade_date": "2010-09-28", "timestamp": "2010-09-28", "mins": 8466644}, {"id": "0001144204-10-051799", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Mark Dyne", "who_key": "DYNE MARK", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410051799/0001144204-10-051799-index.htm", "trade_date": "2010-09-28", "timestamp": "2010-09-28", "mins": 8466644}, {"id": "0001144204-10-051801", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Robert S. Ellin", "who_key": "ELLIN ROBERT S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410051801/0001144204-10-051801-index.htm", "trade_date": "2010-09-28", "timestamp": "2010-09-28", "mins": 8466644}, {"id": "0001144204-10-036315", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Thomas Plotts", "who_key": "Plotts Thomas", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410036315/0001144204-10-036315-index.htm", "trade_date": "2010-06-30", "timestamp": "2010-06-30", "mins": 8596244}, {"id": "0001144204-10-032251", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Mark Dyne", "who_key": "DYNE MARK", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410032251/0001144204-10-032251-index.htm", "trade_date": "2010-06-03", "timestamp": "2010-06-03", "mins": 8635124}, {"id": "0001144204-10-034971", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Thomas Plotts", "who_key": "Plotts Thomas", "role": "Interim CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 7968.759999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410034971/0001144204-10-034971-index.htm", "trade_date": "2010-03-31", "timestamp": "2010-03-31", "mins": 8727284}, {"id": "0001144204-10-004988", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Thomas Plotts", "who_key": "Plotts Thomas", "role": "Interim CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410004988/0001144204-10-004988-index.htm", "trade_date": "2010-01-29", "timestamp": "2010-01-29", "mins": 8815124}, {"id": "0001144204-10-004581", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Jeffrey A. Schwartz", "who_key": "SCHWARTZ JEFFREY A", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410004581/0001144204-10-004581-index.htm", "trade_date": "2010-01-27", "timestamp": "2010-01-27", "mins": 8818004}, {"id": "0001144204-10-011624", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Jerome A. Chazen", "who_key": "CHAZEN JEROME A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410011624/0001144204-10-011624-index.htm", "trade_date": "2010-01-20", "timestamp": "2010-01-20", "mins": 8828084}, {"id": "0001144204-10-001028", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Trinad Capital Master Fund Ltd.", "who_key": "Trinad Capital Master Fund Ltd.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 534337.3476, "score": 48.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Major holder piles $534K into ATRN", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410001028/0001144204-10-001028-index.htm", "trade_date": "2009-12-21", "timestamp": "2009-12-21", "mins": 8871284}, {"id": "0001144204-09-049330", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Mark Dyne", "who_key": "DYNE MARK", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420409049330/0001144204-09-049330-index.htm", "trade_date": "2009-09-17", "timestamp": "2009-09-17", "mins": 9008084}, {"id": "0001144204-09-035076", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "NEW MOTION, INC.", "company_raw": "NEW MOTION, INC.", "who": "Andrew Zaref", "who_key": "ZAREF ANDREW", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420409035076/0001144204-09-035076-index.htm", "trade_date": "2009-06-25", "timestamp": "2009-06-25", "mins": 9129044}, {"id": "0001144204-09-035307", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Andrew Stollman", "who_key": "STOLLMAN ANDREW", "role": "President", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "President files routine paperwork on ATRN \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420409035307/0001144204-09-035307-index.htm", "trade_date": "2009-06-25", "timestamp": "2009-06-25", "mins": 9129044}], "recent_buys": [{"id": "0001144204-10-067071", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Raymond Musci", "who_key": "MUSCI RAYMOND", "role": "Exec VP, Corporate Development, Director", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 28457.94, "score": 33.3, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "A director backs ATRN with $28K", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410067071/0001144204-10-067071-index.htm", "trade_date": "2010-12-13", "timestamp": "2010-12-13", "mins": 8357204}, {"id": "0001144204-10-066734", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Raymond Musci", "who_key": "MUSCI RAYMOND", "role": "Exec VP, Corporate Development, Director", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 28457.94, "score": 32.8, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "A director backs ATRN with $28K", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410066734/0001144204-10-066734-index.htm", "trade_date": "2010-12-13", "timestamp": "2010-12-13", "mins": 8357204}, {"id": "0001144204-10-001028", "src": "INSIDERS", "ticker": "ATRN", "cik": "1022899", "company": "Atrinsic, Inc.", "company_raw": "Atrinsic, Inc.", "who": "Trinad Capital Master Fund Ltd.", "who_key": "Trinad Capital Master Fund Ltd.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 534337.3476, "score": 48.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Major holder piles $534K into ATRN", "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410001028/0001144204-10-001028-index.htm", "trade_date": "2009-12-21", "timestamp": "2009-12-21", "mins": 8871284}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Trinad Capital Master Fund Ltd.", "who_key": "Trinad Capital Master Fund Ltd.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 534337.3476, "sold": 0, "net": 534337.3476, "trades": 1, "top_score": 48.3, "lean": "buying", "history": [{"action": "BUY", "amount": 534337.3476, "date": "2009-12-21", "score": 48.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410001028/0001144204-10-001028-index.htm"}], "latest": {"action": "BUY", "amount": 534337.3476, "date": "2009-12-21", "score": 48.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410001028/0001144204-10-001028-index.htm"}}, {"who": "Raymond Musci", "who_key": "MUSCI RAYMOND", "role": "Exec VP, Corporate Development, Director", "person_type": "EXEC", "person_label": "Execs", "bought": 56915.88, "sold": 0, "net": 56915.88, "trades": 2, "top_score": 33.3, "lean": "buying", "history": [{"action": "BUY", "amount": 28457.94, "date": "2010-12-13", "score": 32.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410066734/0001144204-10-066734-index.htm"}, {"action": "BUY", "amount": 28457.94, "date": "2010-12-13", "score": 33.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410067071/0001144204-10-067071-index.htm"}], "latest": {"action": "BUY", "amount": 28457.94, "date": "2010-12-13", "score": 32.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1022899/000114420410066734/0001144204-10-066734-index.htm"}}], "activity": [], "announcements": [{"form": "4", "date": "2026-08-24", "title": "Insider transaction", "accession": "0001493152-26-039816", "price_sensitive": false}, {"form": "4", "date": "2026-08-20", "title": "Insider transaction", "accession": "0001493152-26-039537", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-20", "title": "Material event", "accession": "0001493152-26-039410", "price_sensitive": true}, {"form": "4", "date": "2026-08-20", "title": "Insider transaction", "accession": "0001493152-26-039399", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-19", "title": "Quarterly report", "accession": "0001493152-26-039221", "price_sensitive": true}, {"form": "NT 10-Q", "date": "2026-08-14", "title": "Form NT 10-Q", "accession": "0001493152-26-038256", "price_sensitive": false}, {"form": "10-K", "date": "2026-08-14", "title": "Annual report", "accession": "0001493152-26-038255", "price_sensitive": true}, {"form": "4", "date": "2026-08-12", "title": "Insider transaction", "accession": "0001493152-26-037468", "price_sensitive": false}, {"form": "4", "date": "2026-08-10", "title": "Insider transaction", "accession": "0001493152-26-036782", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001493152-26-036442", "price_sensitive": false}, {"form": "4", "date": "2026-08-03", "title": "Insider transaction", "accession": "0001493152-26-035868", "price_sensitive": false}, {"form": "NT 10-K", "date": "2026-06-30", "title": "Form NT 10-K", "accession": "0001493152-26-031235", "price_sensitive": false}, {"form": "8-K", "date": "2026-04-07", "title": "Material event", "accession": "0001493152-26-015365", "price_sensitive": true}, {"form": "10-Q", "date": "2026-03-09", "title": "Quarterly report", "accession": "0001493152-26-009301", "price_sensitive": true}, {"form": "8-K", "date": "2026-03-03", "title": "Material event", "accession": "0001493152-26-008605", "price_sensitive": true}, {"form": "8-K", "date": "2026-02-24", "title": "Material event", "accession": "0001493152-26-007800", "price_sensitive": true}, {"form": "NT 10-Q", "date": "2026-02-18", "title": "Form NT 10-Q", "accession": "0001493152-26-007254", "price_sensitive": false}, {"form": "25-NSE", "date": "2026-01-23", "title": "Form 25-NSE", "accession": "0001354457-26-000085", "price_sensitive": false}, {"form": "8-K", "date": "2026-01-05", "title": "Material event", "accession": "0001493152-26-000263", "price_sensitive": true}, {"form": "DEF 14A", "date": "2025-12-05", "title": "Proxy statement", "accession": "0001493152-25-026414", "price_sensitive": false}, {"form": "10-Q", "date": "2025-11-26", "title": "Quarterly report", "accession": "0001493152-25-025201", "price_sensitive": true}, {"form": "8-K", "date": "2025-11-26", "title": "Material event", "accession": "0001493152-25-025159", "price_sensitive": true}, {"form": "NT 10-Q", "date": "2025-11-14", "title": "Form NT 10-Q", "accession": "0001493152-25-023624", "price_sensitive": false}, {"form": "8-K", "date": "2025-11-05", "title": "Material event", "accession": "0001493152-25-020881", "price_sensitive": true}, {"form": "8-K", "date": "2025-10-31", "title": "Material event", "accession": "0001493152-25-020444", "price_sensitive": true}], "performance": {"ticker": "ATRN", "has_prices": false, "summary": null, "buys": [{"who": "MUSCI RAYMOND", "person_type": "EXEC", "person_label": "Execs", "role": "Exec VP, Corporate Development, Director", "amount": 28457.94, "date": "2010-12-13", "score": 33.3, "ref_price": null, "return": null}, {"who": "MUSCI RAYMOND", "person_type": "EXEC", "person_label": "Execs", "role": "Exec VP, Corporate Development, Director", "amount": 28457.94, "date": "2010-12-13", "score": 32.8, "ref_price": null, "return": null}, {"who": "Trinad Capital Master Fund Ltd.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 534337.3476, "date": "2009-12-21", "score": 48.3, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}